Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gabriela Silvina Bacchini"'
Autor:
David Montani, José M. Cifrián, Raquel P. Rojo, Hilario Nunes, Federica Meloni, Stefano Ghio, John Cannon, Andreas Günther, Héctor Gálvez García, Míriam Fernández Delgado, Gabriela Silvina Bacchini Jeanneret, Luke Howard
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Background With no approved therapies for pulmonary hypertension (PH) associated with interstitial lung disease (PH-ILD) in Europe, we surveyed clinician perceptions on PH-ILD management and unmet need to understand current real-world practices. Meth
Externí odkaz:
https://doaj.org/article/d8768b1e3243444e84f60ff2434829db
Autor:
Lucilla Piccari, Gabor Kovacs, Steve Jones, Hall Skaara, Claudia Roca Herms, Gabriela Silvina Bacchini Jeanneret, Melquiades Calzado Vinardell, Nuria Gonzalez‐Rojas Guix, Miriam Fernandez Delgado, Héctor Gálvez García, David Schwicker
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Pulmonary hypertension (PH) adds a substantial disease burden, including higher mortality, when associated with interstitial lung disease (ILD), a severe, chronic, progressive condition. Yet little is known of the lived experiences, perspect
Externí odkaz:
https://doaj.org/article/f0afdccc6efb47f1b9f7ca5dac0a0c41
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nicolas G. Bazan, Bokkyoo Jun, David Rodríguez Gil, Gabriela Silvina Bacchini, William C. Gordon, Fernando Pineda De La Losa, Ricardo Palacios Pelaez, Hélène Varoqui, Virginia García López, Javier Alcover Díaz, Surjyadipta Bhattacharjee, Concha Tiana Ferrer
Publikováno v:
Dermatology and Therapy
Introduction A major clinical challenge in treating allergic contact dermatitis (ACD) is that the first line of treatment is based on the use of corticosteroids. In this study, we aimed to develop a formulation that is devoid of steroids. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcd1e493be0d211e41f030073a1f564
https://pubmed.ncbi.nlm.nih.gov/29453524
https://pubmed.ncbi.nlm.nih.gov/29453524
Autor:
Montani D; Université Paris-Saclay, AP-HP, INSERM UMR_S 999, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, Hôpital de Bicêtre, Le Kremlin Bicêtre, France., Cifrián JM; Hospital Universitario Marqués De Valdecilla, Pneumology service, Santander, Spain., Rojo RP; 12 de Octubre Hospital, Pneumology Department, Madrid, Spain., Nunes H; Hôpital Avicenne, AP-HP, Service de Pneumologie, Centre de référence des maladies pulmonaires rares, Université Sorbonne Paris Nord, Bobigny, France., Meloni F; Fondazione Policlinico San Matteo and University of Pavia, UOS Transplant Center, Pavia, Italy., Ghio S; Fondazione IRCCS Policlinico S.Matteo, Divisione di Cardiologia, Pavia, Italy., Cannon J; Royal Papworth Hospital, Cambridge, UK., Günther A; Center for Interstitial and Rare Lung Diseases, Justus-Liebig-University Giessen, Giessen, Germany., Gálvez García H; Ferrer, Corporate Medical Affairs, Barcelona, Spain., Delgado MF; Ferrer, Corporate Medical Affairs, Barcelona, Spain., Jeanneret GSB; Ferrer, Corporate Medical Affairs, Barcelona, Spain., Howard L; Imperial College Healthcare NHS Trust, London, UK.
Publikováno v:
ERJ open research [ERJ Open Res] 2024 Jul 08; Vol. 10 (4). Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).